Cypress Capital Management (Delaware)’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Cypress Capital Management (Delaware)’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,612	Closed	-$448K	–	193
2022 Q3	$448K	Hold	1,612	–	–	0.08%	137
2022 Q2	$308K	Hold	1,612	–	–	0.05%	164
2022 Q1	$334K	Hold	1,612	–	–	0.04%	168
2021 Q4	$287K	Hold	1,612	–	–	0.03%	188
2021 Q3	$306K	Hold	1,612	–	–	0.04%	156
2021 Q2	$306K	Hold	1,612	–	–	0.04%	156
2021 Q1	$210K	Buy	+1,612	New	+$193K	0.03%	167

Other funds holding SWAV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cypress Capital Management (Delaware)'s SWAV Position: Q4 2022 in Review

Cypress Capital Management (Delaware) sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2022, closing a stake of 1,612 shares — an estimated $448K sold.

Cypress Capital Management (Delaware) first reported a position in SWAV in Q1 2021 and held it in 7 quarters. The position peaked at $448K in Q3 2022. 413 funds tracked by Wall St. Rank hold SWAV as of Q4 2022.

Cypress Capital Management (Delaware) reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Cypress Capital Management (Delaware) sold 1,612 Shockwave Medical, Inc. Common Stock shares in Q4 2022, an estimated $448K.
Cypress Capital Management (Delaware) first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Cypress Capital Management (Delaware)'s Shockwave Medical, Inc. Common Stock position peaked at $448K in Q3 2022.
413 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2022.

Based on Cypress Capital Management (Delaware)'s 13F filing for Q4 2022.